Skip to Content

IQ Healthy Hearts ETF HART

Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis HART

Will HART outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin IQ Healthy Hearts ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HART

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 51.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Apple Inc

5.56 477,173
Technology

UnitedHealth Group Inc

5.56 476,847
Healthcare

Johnson & Johnson

5.35 459,125
Healthcare

Novartis AG Registered Shares

5.25 449,920
Healthcare

Pfizer Inc

5.18 444,189
Healthcare

Abbott Laboratories

5.10 437,403
Healthcare

Eli Lilly and Co

4.92 422,092
Healthcare

AstraZeneca PLC

4.92 422,079
Healthcare

Alphabet Inc Class A

4.77 409,167
Communication Services

Novo Nordisk A/S Class B

4.67 400,896
Healthcare